RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
GPs remain the frontline in vaccination With the WHO warning global immunisation gains are at risk, an RACGP expert says GPs are best placed to get vaccination rates up.
Using same arm for vaccination boosts antibody response: Study New Australian research suggests that using the same arm for vaccine boosters could trigger a more rapid immune response.
Plan to boost GP numbers in North-East Tasmania unveiled If the Labor Party is re-elected, medical students will be able to complete their entire degree in Launceston for the first time.
New guidance on antibiotic use for childhood acute otitis media The new addition to the RACGP’s First do no harm guide walks GPs through treatment recommendations and shared decision making with patients.
Health groups call on candidates to reveal abortion support The RACGP has joined forces with 39 high-profile health groups, calling on political parties to support improving abortion access for all.
Shingles vaccine linked to dementia risk reduction The new research found those vaccinated had their risk of new dementia diagnoses reduced by 20% over seven years.
‘Hearing real stories is what makes the difference’ An RACGP WA roundtable has brought together grassroots GPs and politicians to discuss and advocate for meaningful change.
Sixty-day scripts slow to find favour: Study With a significantly lower-than-expected uptake, an RACGP expert says this could be caused by software impediments, complexity over medication eligibility, and patient views.
‘Unprecedented’ update to antibiotic guidelines The first tranche of a major update from Therapeutic Guidelines has been released, with a focus on infections treated in primary care.